Fabtech Techn. Q1 FY26 Earnings Analysis

- Fabtech Technologies targets a revenue growth of 30% to 40% for FY 2026 over FY 2025. - Post-2027, a significant market explosion is expected especially in semiconductor, electronics, and cleanroom sectors. - The company is focused on steady growth with annualized results rather than quarter-to-quarter performance. - Growth drivers include expansion in pharma, semiconductor, electronics, solar manufacturing, and data centers. - Reference creation in semiconductor and data center sectors is a key focus area to accelerate growth. - The real momentum for the cleanroom business, especially due to semiconductor investments, is anticipated beyond 2027. - The company plans to leverage acquisitions and inorganic growth to scale rapidly. - Manufacturing capabilities and reference projects are being built to capture larger, high-value cleanroom projects. - Fabtech is taking steps to improve project delivery speed and working capital efficiency to support growth.

- Fabtech Technologies Cleanrooms Limited targets revenue growth of 30% to 40% in FY26, building on strong momentum. - Management expects steady growth at similar rates through FY29, emphasizing an annualized growth story rather than quarter-to-quarter results. - EBITDA margins are expected to remain stable in the 8% to 10% range, with potential short-term margin concessions to build references in semiconductor and data center verticals. - Net profit margins improved significantly in FY25 and are projected to maintain an upward trajectory aligned with revenue growth. - The company is focused on operational excellence, reducing project timelines, and cash flow efficiency to support profitability. - Long-term growth drivers include expansion into semiconductor, electronics, and solar industries, with anticipated accelerated growth post-2027 as investments in these sectors increase. - Management plans sustainable, compounding value creation rather than chasing short-term gains.

- Currently, no major capex is planned except for potential inorganic acquisitions. - Management prefers inorganic growth (acquisitions) as a faster way to expand rather than building infrastructure organically. - Moderate capex may occur to support organic growth, but nothing significant is anticipated at present. - The company is focused on building in-house manufacturing capabilities to enhance value and project control. - Investment in innovative technology like robotic welding machines is being considered to reduce labor dependency and improve efficiency. - Post-2027, with expected industry growth, strategic investments may increase to capitalize on semicon and electronics sector expansion. - Overall, the focus is on sustainable, long-term investments rather than short-term impulsive capex.

- No explicit mention of any planned new fundraising through debt or equity in the provided transcript. - Management emphasizes organic growth and inorganic expansion primarily via acquisitions as a faster growth method. - Moderate capex expected for operations, with major capex only if significant acquisitions occur. - The company focuses on sustainable growth and prudent capital allocation, with no impulsive or short-term fundraising indicated. - No current indications or announcements about raising funds through new equity or debt instruments.

- Current consolidated order book (Fabtech + Kelvin) stands at around INR 90 crores. - The order book split: approximately INR 50-60 crores from pharma; INR 30+ crores from semiconductor, electronics, and solar combined. - There is a robust order pipeline exceeding INR 300 crores across sectors including pharmaceutical, data centers, semiconductor, and solar. - Recent semiconductor order wins include INR 8.4 crores from CG Semi. - Data center orders include INR 2.5 crores from Nexta Data Center (1 floor done; 2 more floors pending) and INR 5.45 crores from National Stock Exchange, with additional INR 4 crores in the pipeline. - Projects have shorter delivery periods now (4-5 months instead of 7-9 months), facilitating faster execution. - Management is confident of achieving revenue growth guidance (30-40% in FY26) supported by this healthy pipeline.